Menu

 

Letter

Drug pricing

PPRS is not NICE

BMJ 2007; 335 doi: http://dx.doi.org/10.1136/bmj.39339.451262.3A (Published 20 September 2007)
Cite this as: BMJ 2007;335:578.3

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Andrea Messori, coordinator
  1. Laboratory of Pharmacoeconomics, Azienda Careggi, 50134 Florence, Italy
  1. andreamessori{at}interfree.it

    Some of Burnand's comments on Iheanacho's article are astonishing.1 If the mission of any national health system is maximising health, this mission is pursued by assuming that spending on a drug buys not the milligrams of the active substance but the clinical …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Latest comments and most commented

    THIS WEEK'S POLL

    Read related article

    See previous polls